Revenue: The sum of all revenue fields included for a company's operating activities.
Elite Pharmaceuticals Inc. (ELTP) had Revenue of $14.36M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$14.36M |
$-10.89M |
|
$8.24M |
|
$6.12M |
|
$13.27M |
|
$1.10M |
|
$-11.75M |
|
$-10.65M |
|
$-10.65M |
|
$-10.89M |
|
$-10.89M |
|
$-10.89M |
|
$-10.89M |
|
$1.10M |
|
$1.59M |
|
1.07B |
|
1.07B |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$48.05M |
|
$9.86M |
|
$42.71M |
|
$90.76M |
|
$14.69M |
|
$4.38M |
|
$39.62M |
|
$54.31M |
|
$36.45M |
|
$29.20M |
|
$36.45M |
|
1.07B |
|
| Cash Flow Statement Financials | |
$3.54M |
|
$-1.65M |
|
$-0.69M |
|
$7.54M |
|
$8.74M |
|
$1.20M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.27 |
|
-- |
|
-- |
|
0.11 |
|
0.25 |
|
42.60% |
|
7.64% |
|
7.64% |
|
-- |
|
-74.16% |
|
-75.83% |
|
$2.79M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.41 |
|
0.78 |
|
115.62 |
|
-29.89% |
|
-37.30% |
|
-12.00% |
|
-26.68% |
|
$0.03 |
|
$0.00 |
|
$0.00 |
|